Department of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Internal Medicine III - Gastroenterology and Infectious Diseases, Augsburg University Hospital, Augsburg, Germany.
Virol J. 2022 Jun 25;19(1):107. doi: 10.1186/s12985-022-01841-y.
Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages. Besides a primary (genetic) form, HLH can also be triggered by malignant, autoimmune and infectious diseases. HLH recurrences are rarely described, usually only in primary HLH. Parvovirus B19 (PVB19) Infection is one of the rare and rather benign causes of HLH. Since the infection usually results in long-lasting immunity, recurrent viremia is very uncommon.
We report an unusual case of a young female with recurrent PVB19 infection that led to repeated episodes of HLH. The first episode occurred at the age of 25 years with a three-week history of high fever and nonspecific accompanying symptoms. The diagnosis of HLH was confirmed by HLH-2004 criteria and HScore, PVB19 viremia was detected as underlying cause. Following guideline-based therapy, the patient was symptom-free for one year, before similar symptoms recurred in a milder form. Again, PVB19 was detected and HLH was diagnosed according to HScore. After successful treatment and a nine-month symptom-free interval, a third phase of hyperinflammation with low PVB19 viremia occurred; this time, treatment with a corticosteroid and intravenous immunoglobulin was initiated before the presence of clear diagnostic criteria for HLH. No further events occurred in the following three years.
In the case of our patient, the recurrent viremia triggered three episodes of hyperinflammation, two of which were clearly diagnosed as HLH. To our knowledge, this is the first published case of recurrent HLH due to PVB19 infection. Therefore, the case gives new insights in triggering mechanisms for HLH.
噬血细胞性淋巴组织细胞增生症(HLH)是一种炎症反应失控的疾病,涉及淋巴细胞和巨噬细胞的过度激活。除了原发性(遗传)形式外,HLH也可由恶性、自身免疫和感染性疾病触发。HLH 的复发很少见,通常仅见于原发性 HLH。细小病毒 B19(PVB19)感染是 HLH 的罕见且相对良性原因之一。由于感染通常会导致持久的免疫力,因此反复病毒血症非常罕见。
我们报告了一例年轻女性复发性 PVB19 感染导致反复发生 HLH 的不寻常病例。首次发作发生在 25 岁时,有三周的高热和非特异性伴随症状史。HLH-2004 标准和 HScore 证实了 HLH 的诊断,检测到 PVB19 病毒血症是潜在病因。根据指南进行治疗后,患者在一年无症状,随后症状以较轻的形式再次复发。同样,检测到 PVB19 并根据 HScore 诊断为 HLH。在成功治疗和九个月无症状间隔后,出现了第三个炎症过度活跃期,此时在明确的 HLH 诊断标准出现之前,开始使用皮质类固醇和静脉注射免疫球蛋白进行治疗。在接下来的三年中没有再发生其他事件。
在我们的患者病例中,反复的病毒血症引发了三次炎症过度活跃期,其中两次明确诊断为 HLH。据我们所知,这是首例复发性 PVB19 感染引起的 HLH 病例。因此,该病例为 HLH 的触发机制提供了新的见解。